Barber Daniel

CIK 00017422661 companyWARREN, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001742266

Recent Transactions

33 trades

Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2026-07-16$4.00/sh−20,369→ 610,574 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2026-07-15$4.03/sh−4,631→ 630,943 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2026-06-15$4.16/sh−25,000→ 635,574 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2026-05-15$4.29/sh−8,257→ 660,574 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2026-05-05$4.18/sh−335,922→ 668,831 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2026-03-10$4.17/sh−180,677→ 1,004,753 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2026-03-09+262,000→ 1,185,430 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2026-03-09$4.29/sh+523,000→ 523,000 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-09-26$6.03/sh−91,343→ 923,430 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-09-19$6.00/sh−400→ 1,014,773 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-03-09$2.65/sh−53,998→ 1,015,173 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-03-07$2.65/sh−29,307→ 1,069,171 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2025-03-07+408,000→ 408,000 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-03-07+272,000→ 1,098,478 total
Award
Aquestive Therapeutics, Inc.$AQST
Performance Stock Units
2025-03-07+293,100→ 293,100 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-03-09$4.88/sh−37,938→ 845,364 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-03-09$4.88/sh−56,824→ 826,478 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-03-07+242,600→ 883,302 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2024-03-07+363,900→ 363,900 total
Award
Aquestive Therapeutics, Inc.$AQST
Performance Stock Units
2023-08-09+223,500→ 223,500 total
Award
Aquestive Therapeutics, Inc.$AQST
Performance Stock Units
2023-05-05+223,500→ 223,500 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2023-03-09+447,000→ 640,702 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2022-08-05+100,000→ 100,000 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Warrant (Right to Buy)
2022-06-08$0.13/sh+91,743→ 91,743 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Common Stock
2022-06-08$0.96/sh+91,743→ 193,702 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2022-03-10+225,000→ 225,000 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2021-03-11+100,000→ 100,000 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2020-03-16+110,000→ 110,000 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-08-27$3.99/sh+2,000→ 101,959 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2019-05-09+50,000→ 50,000 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2019-02-28+70,000→ 70,000 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Common Stock
2018-12-10$8.00/sh+1,000→ 99,959 total
Award
Aquestive Therapeutics, Inc.$AQST
Stock Option (Right to Purchase)
2018-07-24+96,507→ 96,507 total

Companies

Aquestive Therapeutics, Inc.
President and CEO
$AQST

Recent Filings

Address

C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE

WARREN, NJ, 07059

View on SEC.gov